| pubmed-article:3199672 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3199672 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3199672 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:3199672 | lifeskim:mentions | umls-concept:C0043227 | lld:lifeskim |
| pubmed-article:3199672 | lifeskim:mentions | umls-concept:C0014822 | lld:lifeskim |
| pubmed-article:3199672 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:3199672 | lifeskim:mentions | umls-concept:C1563350 | lld:lifeskim |
| pubmed-article:3199672 | lifeskim:mentions | umls-concept:C1516240 | lld:lifeskim |
| pubmed-article:3199672 | lifeskim:mentions | umls-concept:C1563351 | lld:lifeskim |
| pubmed-article:3199672 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:3199672 | pubmed:dateCreated | 1989-1-25 | lld:pubmed |
| pubmed-article:3199672 | pubmed:abstractText | To investigate the effect of partial correction of anemia in patients maintained by chronic intermittent hemodialysis on aerobic and anaerobic working capacity, eight patients underwent a bicycle spiro-ergometry before and after treatment with recombinant human erythropoietin (r-HuEPO). the initial mean (+/- SD) hemoglobin value was 5.9 mg/dl +/- 0.61 and increased during treatment to 10.9 +/- 0.59 mg/dl, P less than 0.0001). This partial correction of anemia resulted in a significant increase of both oxygen uptake at the anaerobic threshold and peak peripheral oxygen uptake at subjective exhaustion (P less than 0.01 and P less than 0.0002, respectively). The increase in oxygen uptake corresponded to significant increases in Watts, both at the anaerobic threshold and at maximum workload (P less than 0.02 and P less than 0.0004). These data show that partial correction of renal anemia results in a significant increase of both exercise capacity and maximum work. | lld:pubmed |
| pubmed-article:3199672 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3199672 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3199672 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3199672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3199672 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3199672 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3199672 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:3199672 | pubmed:issn | 0085-2538 | lld:pubmed |
| pubmed-article:3199672 | pubmed:author | pubmed-author:GrafHH | lld:pubmed |
| pubmed-article:3199672 | pubmed:author | pubmed-author:StummvollH... | lld:pubmed |
| pubmed-article:3199672 | pubmed:author | pubmed-author:MayerGG | lld:pubmed |
| pubmed-article:3199672 | pubmed:author | pubmed-author:ThumJJ | lld:pubmed |
| pubmed-article:3199672 | pubmed:author | pubmed-author:CadaE MEM | lld:pubmed |
| pubmed-article:3199672 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3199672 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:3199672 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3199672 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3199672 | pubmed:pagination | 525-8 | lld:pubmed |
| pubmed-article:3199672 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:meshHeading | pubmed-meshheading:3199672-... | lld:pubmed |
| pubmed-article:3199672 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3199672 | pubmed:articleTitle | Working capacity is increased following recombinant human erythropoietin treatment. | lld:pubmed |
| pubmed-article:3199672 | pubmed:affiliation | 2nd Department of Medicine, University of Vienna, Austria. | lld:pubmed |
| pubmed-article:3199672 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3199672 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3199672 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3199672 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3199672 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3199672 | lld:pubmed |
